Supernus Pharmaceuticals (S49) Revenue

1 Followers

Supernus Pharmaceuticals Revenue

Supernus Pharmaceuticals had a revenue of 219.06M in the quarter ending Jun 30, 2026, with 5.47%. This bring the company's revenue in the last twelve months to 830.44M, Decreased 6.90%. In the fiscal year ending Dec 31, 2025, Supernus Pharmaceuticals had annual revenue of 718.95M with 8.63% growth.

Revenue (ttm)

830.44M

Revenue Growth

―

P/S Ratio

2.85

Revenue/Employee

CHF924,103

Employees

778

Market Cap

CHF2.05B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	718.95M	57.13M	+8.63%
Dec 31, 2024	661.82M	54.30M	+8.94%
Dec 31, 2023	607.52M	-59.72M	-8.95%
Dec 31, 2022	667.24M	87.46M	+15.09%
Dec 31, 2021	579.77M	59.38M	+11.41%
Dec 31, 2020	520.40M	127.64M	+32.50%
Dec 31, 2019	392.75M	-16.14M	-3.95%
Dec 31, 2018	408.90M	106.66M	+35.29%
Dec 31, 2017	302.24M	―	―